Analytical Data
-
基因名
MOSC1
- Application
-
别名
Molybdenum Cofactor Sulphurase C-Terminal Domain Containing Protein; Mitochondrial amidoxime-reducing component 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5VT66
-
表达区间
Arg41~Leu335
-
分子量
37kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MOSC1, or Mitosuppressor Component 1, is a highly conserved protein implicated in various cellular processes, including mitochondrial function and cellular stress responses. Its study has gained traction due to its potential role in cancer biology and cellular homeostasis. Research has shown that MOSC1 is involved in the regulation of mitochondrial dynamics, promoting the repair and maintenance of mitochondrial integrity. Dysregulation of MOSC1 expression has been linked to various pathologies, including neurodegenerative diseases and cancer, where its aberrant signaling may influence tumorigenesis and metastasis. The exploration of MOSC1 as a recombinant protein holds promise for unraveling its biochemical pathways and interactions, which can provide insights into its functional roles within the cell. Furthermore, the development of MOSC1-based therapeutics could offer novel strategies for targeting mitochondrial dysfunctions in disease contexts. Understanding the molecular mechanisms mediated by MOSC1 and its interactions with various cellular components is critical for elucidating its contributions to both normal physiology and disease progression. Thus, extensive research into the recombinant production and characterization of MOSC1 is essential for advancing our knowledge of its biological significance and therapeutic potential.
